Search by Drug Name or NDC

    NDC 00536-1333-36 Guaifenesin D 600; 60 mg/1; mg/1 Details

    Guaifenesin D 600; 60 mg/1; mg/1

    Guaifenesin D is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by RUGBY LABORATORIES, INC.. The primary component is GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE.

    Product Information

    NDC 00536-1333
    Product ID 0536-1333_4f4c9058-ec1c-48d5-81df-56188b7ae803
    Associated GPIs 43996202307435
    GCN Sequence Number 012073
    GCN Sequence Number Description guaifenesin/pseudoephedrne HCl TAB ER 12H 600MG-60MG ORAL
    HIC3 B4W
    HIC3 Description DECONGESTANT-EXPECTORANT COMBINATIONS
    GCN 54980
    HICL Sequence Number 000270
    HICL Sequence Number Description GUAIFENESIN/PSEUDOEPHEDRINE HCL
    Brand/Generic Generic
    Proprietary Name Guaifenesin D
    Proprietary Name Suffix n/a
    Non-Proprietary Name Guaifenesin and Pseudoephedrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 600; 60
    Active Ingredient Units mg/1; mg/1
    Substance Name GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE
    Labeler Name RUGBY LABORATORIES, INC.
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA212542
    Listing Certified Through 2024-12-31

    Package

    NDC 00536-1333-36 (00536133336)

    NDC Package Code 0536-1333-36
    Billing NDC 00536133336
    Package 2 BLISTER PACK in 1 CARTON (0536-1333-36) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2022-04-04
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.35738
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description GUAIFENESIN-PSE ER 600-60 MG
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 997946e6-eff0-4c15-8694-020a19c2d336 Details

    Revised: 5/2022